Position in QTTB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,057,494
+$993,494 QoQ
Shares Held
320,482
0.0% QoQ
Ownership
1.89%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QTTB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARCH Venture Management, LLC holds $672,473,115 across 9 Biotechnology names. QTTB ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MAZE |
Maze Therapeutics, Inc.
|
4,120,053 | $122,983,582 | |
| 2 | RAPP |
Rapport Therapeutics, Inc.
|
3,728,738 | $116,672,212 | |
| 3 | VIR |
Vir Biotechnology, Inc.
|
12,916,663 | $115,733,300 | |
| 4 | ERAS |
Erasca, Inc.
|
7,091,557 | $114,741,392 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
4,540,132 | $108,191,345 | |
| 6 | LYEL |
Lyell Immunopharma, Inc.
|
3,247,162 | $65,138,069 | |
| 7 | GENB |
Generate Biomedicines, Inc.
|
1,944,426 | $24,305,325 | |
| 8 | GOSS |
Gossamer Bio, Inc.
|
8,055,916 | $2,650,396 |
All Filings in QTTB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,057,494 | 320,482 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,064,000 | 320,482 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $634,554 | 320,482 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $477,518 | 320,482 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $528,795 | 320,482 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,102,458 | 320,482 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,299,906 | 320,482 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,752,651 | 320,482 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,461,013 | 320,482 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||